| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 172,460 | 153,604 | 149,312 | 172,510 | | Cost of Revenue | 121,138 | 108,009 | 107,131 | 111,722 | | | Gross Profit | 51,322 | 45,595 | 42,181 | 60,788 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 38,262 | 35,038 | 33,496 | 33,753 | | Non Recurring | 3,628 | 1,193 | 2,783 | 95 | | Others | 1,681 | 898 | 867 | 968 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 7,751 | 8,466 | 5,035 | 25,972 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 809 | 1,006 | 1,282 | | Earnings Before Interest And Taxes | 8,403 | 9,275 | 6,041 | 27,254 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 8,403 | 9,275 | 6,041 | 27,254 | | Income Tax Expense | 2,470 | 1,679 | 1,543 | 1,535 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 5,933 | 7,596 | 4,498 | 25,719 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 5,933 | 7,596 | 4,498 | 25,719 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $5,933 | $7,596 | $4,498 | $25,719 |
|
0.28% Nasdaq 
Income Statement
